iHuman Inc. Sponsored ADR (NYSE:IH – Get Free Report)’s share price was up 2.1% during mid-day trading on Wednesday . The stock traded as high as $2.98 and last traded at $2.95. Approximately 7,610 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 18,912 shares. The stock had previously closed at $2.89.
iHuman Stock Up 2.1%
The firm has a fifty day moving average of $2.84 and a 200-day moving average of $2.50. The firm has a market cap of $153.46 million, a P/E ratio of 10.17 and a beta of 0.39.
iHuman (NYSE:IH – Get Free Report) last posted its quarterly earnings results on Thursday, September 18th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $27.94 million for the quarter. iHuman had a return on equity of 11.59% and a net margin of 12.46%.
Hedge Funds Weigh In On iHuman
iHuman Company Profile
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
Further Reading
- Five stocks we like better than iHuman
- Why Invest in High-Yield Dividend Stocks?
- Datavault AI: The New AI Contender Backed by Big Funding
- What is a Low P/E Ratio and What Does it Tell Investors?
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.